Richard T. Smith
Baylor College of Medicine
19 Papers
432 Citations
Richard T. Smith is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Supraventricular tachycardia & Ventricular tachycardia. The author has an hindex of 15, co-authored 19 publications. Previous affiliations of Richard T. Smith include Boston Children's Hospital & University of Arkansas for Medical Sciences.
Chat about Author
Papers
Fetal Ventricular Pacing for Hydrops Secondary to Complete
Janette F. Strasburger,Richard T. Smith,Russell L. Deter +2 more
- 01 Jan 2013
TL;DR: In this paper, the application of ventricular pacing in a hydropic fetus with complete atrioventricular (AV) block was reported to allow further in utero deformation and for reversal of hydrops fetalis after improvement in cardiacoutput.
157
Pediatric Nonpost-Operative Junctional Ectopic Tachycardia: Medical Management and Interventional Therapies
Kathryn K. Collins,George F. Van Hare,Naomi J. Kertesz,Ian H. Law,Yaniv Bar-Cohen,Anne M. Dubin,Susan P. Etheridge,Charles I. Berul,Jennifer N. Avari,Volkan Tuzcu,Narayanswami Sreeram,Michael Schaffer,Anne Fournier,Shubhayan Sanatani,Christopher S. Snyder,Richard T. Smith,Luis Arabia,Robert J. Hamilton,Terrence Chun,Leonardo Liberman,Bahram Kakavand,Thomas Paul,Ronn E. Tanel +22 more
TL;DR: Patients with nonpost-operative JET have a wide range of clinical presentations, with younger patients demonstrating higher morbidity and mortality, with the majority of patients having a good clinical outcome.
142
Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.
James C. Perry,Roy L. McQuinn,Richard T. Smith,Cheryl Gothing,Patricia Fredell,Arthur Garson +5 more
TL;DR: Drug efficacy and pharmacokinetics were assessed in 63 patients, aged 5 days to 30 years, who received flecainide acetate for control of resistant arrhythmias and patients with Wolff-Parkinson-White syndrome developed asymptomatic, incessant, slower orthodromic reciprocating tachycardia while receiving the drug.
91
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.
Seshadri Balaji,Michael P. DiLorenzo,Frank A. Fish,Susan P. Etheridge,Peter F. Aziz,Mark W. Russell,Svjetlana Tisma,Andreas Pflaumer,Narayanswami Sreeram,Peter Kubuš,Ian H. Law,Michal J. Kantoch,Naomi J. Kertesz,Margaret J. Strieper,Christopher C. Erickson,Jeremy P. Moore,Stephanie J. Nakano,Harinder R. Singh,Philip Chang,Mitchell B. Cohen,Anne Fournier,Maria Ilina,Richard T. Smith,Frank Zimmerman,Michaela Horndasch,Walter Li,Anjan S. Batra,Leonardo Liberman,Robert J. Hamilton,Christopher M. Janson,Shubhayan Sanatani,Ilana Zeltser,George McDaniel,Andrew D. Blaufox,Jason M. Garnreiter,Hannah Katcoff,Maully J. Shah +36 more
TL;DR: Risk factors for LAE appear different in children compared to adults, and conventional adult risk factors were not significant in children.
66
Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia
Arthur Garson,Arthur Garson,Jeffrey P. Moak,Jeffrey P. Moak,Richard T. Smith,Richard T. Smith,J.B. Norton,J.B. Norton +7 more
TL;DR: JET is one of the most dangerous arrhythmias that occur in the immediate postoperative period after surgical repair of congenital cardiac defects and propafenone was chosen specifically for its effect on automaticity in attempting to control postoperative JET.
64